Latest News
Latest News
Women Are Entering Higher-Paid MD Specialties at Higher Rates
It will take time for the dominance of women among medical students to translate into more representation in the physician workforce.
Conference Coverage
sNFl and sGFAP Predict MS Disability in Unique Ways
GFAP might soon join serum neurofilament light chain (sNFl) levels for predicting disability, but each has unique features and they appear to...
Latest News
Millennial Clinicians Face Pay Disparities by Specialty, Other Factors
“Procedures are reimbursed too high, while very little value is placed on primary care.”
Conference Coverage
Time to Revisit the Standard Treatment Approach in Children With MS?
Only a few medications are licensed for pediatric use, indicating it may be time to reconsider the standard treatment approach for this patient...
Conference Coverage
Investigational Med for Tourette Syndrome Promising
Ecopipam reduced the primary endpoint of tic severity scores by 30% compared with placebo among 149 patients in the 12-week, phase 2b D1AMOND...
Latest News
A Few Rural Towns Are Bucking the Trend and Building New Hospitals
New full-service hospitals with inpatient beds are rare in rural America, where declining population has spurred decades of downsizing and...
Conference Coverage
Undertreatment of Women With MS Unjustified
“We believe that pregnancy-related considerations probably still explain the major part of this gap.”
Conference Coverage
Antidepressants Linked to Improved Verbal Memory
The clinical effect may be linked to changes in serotonin 4 (5-HT4) receptor levels in the brain.
Feature
Popular Weight Loss Drugs Now for Patients With Cancer?
Research suggests that obesity can reduce the effectiveness of cancer therapies.
News
Prominent NIH Neuroscientist Fired Over Alleged Research Misconduct
The misconduct involved “falsification and/or fabrication involving reuse and relabel of figure panels representing different experimental results...
Rare Disease Report 2024
Editor's Note: 2024 Rare Neurological Disease Report
EDITOR’S NOTE
This year, we again focus on rare neurological diseases that have new therapies that have been recently approved as well as...